A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone(®) 3.75 mg in healthy male subjects

Leuprolide acetate microspheres developed by Shanghai Livzon Pharmaceutical Co., Ltd. (T) have been marketed in China for more than 10 years, benefiting a large number of patients, and will continue to play an important role in China. However, as a generic drug, it is unclear whether there is a diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xingjiang, Zhang, Qiao, Zheng, Yunliang, Zhai, You, Xu, Nana, Zhao, Qingwei, Liu, Jian, Wan, Longyan, Luo, Jindan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437282/
https://www.ncbi.nlm.nih.gov/pubmed/36059939
http://dx.doi.org/10.3389/fphar.2022.946505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437282/
https://www.ncbi.nlm.nih.gov/pubmed/36059939
http://dx.doi.org/10.3389/fphar.2022.946505

Ejemplares similares